Research shows diabetes drug could reduce dementia risk—here’s how the two diseases may be linked

Medical Xpress September 4, 2024
Steve Macfarlane, The Conversation

A Korean study published recently suggests that people with type 2 diabetes who are prescribed a particular class of drug might be at a significantly lower risk of dementia.

The researchers compared the health outcomes of more than 110,000 people aged 40–69 with type 2 diabetes who had been prescribed a type of drug called SGLT-2 inhibitors with those of another 110,000 patients taking a different class of drug, DPP-4 inhibitors. They followed participants for an average of 670 days.

The researchers found that after accounting for potential confounding factors, those taking an SGLT-2 inhibitor were 35% less likely to develop dementia.

Diabetes is recognized as a risk factor for dementia. So it’s not entirely surprising that treating diabetes could...

Today's Sponsors

Today's Sponsor